Home/Filings/4/0001209191-23-038144
4//SEC Filing

Ribas Antoni 4

Accession 0001209191-23-038144

CIK 0001724521other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 8:06 PM ET

Size

8.0 KB

Accession

0001209191-23-038144

Insider Transaction Report

Form 4
Period: 2023-06-15
Ribas Antoni
Director
Transactions
  • Award

    Common Stock

    2023-06-15+6,80021,950 total
  • Award

    Stock Option (Right to Buy)

    2023-06-15+19,50019,500 total
    Exercise: $19.60Exp: 2033-06-14Common Stock (19,500 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,553
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
  • [F2]The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001792164

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:06 PM ET
Size
8.0 KB